Skip to content

RELMADA THERAPEUTICS, INC.

RLMD · XNAS

CIK 1553643fmd_1TPEDSD1WCA743C4KRYHCF5QWVManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2005 to Sep 30, 2026, 72 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading